X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs SUVEN LIFE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA SUVEN LIFE ELDER PHARMA/
SUVEN LIFE
 
P/E (TTM) x -0.2 16.3 - View Chart
P/BV x 0.1 3.0 3.3% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 ELDER PHARMA   SUVEN LIFE
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
SUVEN LIFE
Mar-16
ELDER PHARMA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs380339 112.3%   
Low Rs188144 130.2%   
Sales per share (Unadj.) Rs491.239.2 1,251.6%  
Earnings per share (Unadj.) Rs-3.27.5 -42.6%  
Cash flow per share (Unadj.) Rs14.48.8 164.2%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.549.0 768.4%  
Shares outstanding (eoy) m20.54127.28 16.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.66.2 9.4%   
Avg P/E ratio x-89.332.4 -275.8%  
P/CF ratio (eoy) x19.727.5 71.6%  
Price / Book Value ratio x0.84.9 15.3%  
Dividend payout %026.8 0.0%   
Avg Mkt Cap Rs m5,83330,732 19.0%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m2,179416 523.3%   
Avg. sales/employee Rs ThNM5,236.1-  
Avg. wages/employee Rs ThNM436.5-  
Avg. net profit/employee Rs ThNM995.5-  
INCOME DATA
Net Sales Rs m10,0894,995 202.0%  
Other income Rs m257194 132.6%   
Total revenues Rs m10,3465,189 199.4%   
Gross profit Rs m-7921,233 -64.2%  
Depreciation Rs m361167 216.1%   
Interest Rs m2,75654 5,085.4%   
Profit before tax Rs m-3,6531,205 -303.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125255 49.1%   
Profit after tax Rs m-65950 -6.9%  
Gross profit margin %-7.824.7 -31.8%  
Effective tax rate %-3.421.2 -16.2%   
Net profit margin %-0.619.0 -3.4%  
BALANCE SHEET DATA
Current assets Rs m9,2404,986 185.3%   
Current liabilities Rs m9,9981,042 959.3%   
Net working cap to sales %-7.579.0 -9.5%  
Current ratio x0.94.8 19.3%  
Inventory Days Days4661 75.9%  
Debtors Days Days6039 153.2%  
Net fixed assets Rs m10,1243,126 323.9%   
Share capital Rs m206127 161.6%   
"Free" reserves Rs m5,5823,717 150.2%   
Net worth Rs m7,7346,236 124.0%   
Long term debt Rs m4,889432 1,130.9%   
Total assets Rs m22,8828,079 283.2%  
Interest coverage x-0.323.2 -1.4%   
Debt to equity ratio x0.60.1 912.0%  
Sales to assets ratio x0.40.6 71.3%   
Return on assets %11.812.4 94.6%  
Return on equity %-0.815.2 -5.5%  
Return on capital %22.318.9 118.2%  
Exports to sales %3.087.5 3.5%   
Imports to sales %0.412.2 3.5%   
Exports (fob) Rs m3074,371 7.0%   
Imports (cif) Rs m43611 7.1%   
Fx inflow Rs m3074,666 6.6%   
Fx outflow Rs m125942 13.3%   
Net fx Rs m1813,724 4.9%   
CASH FLOW
From Operations Rs m11,754922 1,274.8%  
From Investments Rs m-561-619 90.5%  
From Financial Activity Rs m-6,762-698 968.2%  
Net Cashflow Rs m4,432-396 -1,120.0%  

Share Holding

Indian Promoters % 39.6 63.4 62.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 16.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 36.5 98.9%  
Shareholders   16,479 37,287 44.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   NOVARTIS  ASTRAZENECA PHARMA  STRIDES SHASUN LTD  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Red; Infosys Tanks as CEO Vishal Sikka Resigns(09:30 am)

Asian indices are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.2%, while the Hang Seng is down 0.7%. The Nikkei 225 is trading lower by 0.9%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - CIPLA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS